Spatially-resolved tumour infiltrating immune cells and prognosis in breast cancer

Aaron J. Bernstein, Renske Keeman, Amber Hurson, Fiona M. Blows, Manjeet K. Bolla, Jodi L. Miller, Roger Milne, Hugo Horlings, Alexandra J. van den Broek, Clara Bodelon, James Hodge, Alpa Patel, Lauren R. Teras, Federico Canzian, Rudolf Kaaks, Hermann Brenner, Ben Schoettker, Sabine Behrens, Jenny Chang-Claude, Tabea Maurer, Nadia Obi, Fergus Couch, H. Raza Ali, Carlos Caldas, Irene Andrulis, Gord Glendon, Anna Marie Mulligan, Wilma Mesker, Agnes Jager, Annette Heemskerk-Gerritsen, Peter Devilee, Scott M. Lawrence, Jolanta Lissowska, Karun Mutreja, Thomas Ahearn, Stephen Chanock, Maire A. Duggan, Diana Eccles, J. Louise Jones, Will Tapper, Antoinette Hollestelle, Maartje Hooning, John Martens, Carolien H.M. van Deurzen, Angela Cox, Simon S. Cross, Mikael Hartman, Jingmei Li, Thomas C. Putti, Ute Hamann, Ania Jakubowska, Nicki Camp, Melissa H. Cessna, Amy Berrington de Gonzalez, Katarzyna Bialkowska, Jacek Gronwald, Jan Lubi_ski, Siddhartha Yadav, Pietro Lio, Doug F. Easton, Mustapha Abubakar, Montse Garcia-Closas, Paul D.P. Pharoah, Marjanka K. Schmidt
{"title":"Spatially-resolved tumour infiltrating immune cells and prognosis in breast cancer","authors":"Aaron J. Bernstein, Renske Keeman, Amber Hurson, Fiona M. Blows, Manjeet K. Bolla, Jodi L. Miller, Roger Milne, Hugo Horlings, Alexandra J. van den Broek, Clara Bodelon, James Hodge, Alpa Patel, Lauren R. Teras, Federico Canzian, Rudolf Kaaks, Hermann Brenner, Ben Schoettker, Sabine Behrens, Jenny Chang-Claude, Tabea Maurer, Nadia Obi, Fergus Couch, H. Raza Ali, Carlos Caldas, Irene Andrulis, Gord Glendon, Anna Marie Mulligan, Wilma Mesker, Agnes Jager, Annette Heemskerk-Gerritsen, Peter Devilee, Scott M. Lawrence, Jolanta Lissowska, Karun Mutreja, Thomas Ahearn, Stephen Chanock, Maire A. Duggan, Diana Eccles, J. Louise Jones, Will Tapper, Antoinette Hollestelle, Maartje Hooning, John Martens, Carolien H.M. van Deurzen, Angela Cox, Simon S. Cross, Mikael Hartman, Jingmei Li, Thomas C. Putti, Ute Hamann, Ania Jakubowska, Nicki Camp, Melissa H. Cessna, Amy Berrington de Gonzalez, Katarzyna Bialkowska, Jacek Gronwald, Jan Lubi_ski, Siddhartha Yadav, Pietro Lio, Doug F. Easton, Mustapha Abubakar, Montse Garcia-Closas, Paul D.P. Pharoah, Marjanka K. Schmidt","doi":"10.1101/2024.07.22.24310819","DOIUrl":null,"url":null,"abstract":"Background\nThe immune response in breast tumors has an important role in prognosis, but the role of spatial localization of immune cells and of interaction between subtypes is not well characterized. We evaluated the association between spatially resolved tissue infiltrating immune cells (TIICs) and breast cancer specific survival (BCSS) in a large multicenter study.\nPatients and methods\nTissue microarrays with tumor cores from 17,265 breast cancer patients of European descent were stained for CD8, FOXP3, CD20, and CD163. We developed a machine learning based tissue segmentation and immune cell detection algorithm using Halo to score each image for the percentage of marker positive cells by compartment (overall, stroma, or tumor). We assessed the association between log transformed TIIC scores and BCSS using Cox regression. Results\nTotal CD8+ and CD20+ TIICs (stromal and intra-tumoral) were associated with better BCSS in women with ER-negative (HR per standard deviation = 0.91 [95% CI 0.85 - 0.98] and 0.89 [0.84 - 0.94] respectively) and ER-positive disease (HR = 0.92 [95% CI 0.87 - 0.98] and 0.93 [0.86 - 0.99] respectively) in multi-marker models. In contrast, CD163+ macrophages were associated with better BCSS in ER-negative disease (0.94 [0.87 - 1.00]) and a poorer BCSS in ER-positive disease 1.04 [0.99 - 1.10]. There was no association between FOXP3 and BCSS. The observed associations tended to be stronger for intra-tumoral than stromal compartments for all markers. However, the TIIC markers account for only 7.6 percent of the variation in BCSS explained by the multi-marker fully-adjusted model for ER-negative cases and 3.0 percent for ER-positive cases.\nConclusions\nThe presence of intra-tumoral and stromal TIICs is associated with better BCSS in both ER-negative and ER-positive breast cancer. This may have implications for the use of immunotherapy. However, the addition of TIICs to existing prognostic models would only result in a small improvement in model performance.","PeriodicalId":501437,"journal":{"name":"medRxiv - Oncology","volume":"53 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.07.22.24310819","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background The immune response in breast tumors has an important role in prognosis, but the role of spatial localization of immune cells and of interaction between subtypes is not well characterized. We evaluated the association between spatially resolved tissue infiltrating immune cells (TIICs) and breast cancer specific survival (BCSS) in a large multicenter study. Patients and methods Tissue microarrays with tumor cores from 17,265 breast cancer patients of European descent were stained for CD8, FOXP3, CD20, and CD163. We developed a machine learning based tissue segmentation and immune cell detection algorithm using Halo to score each image for the percentage of marker positive cells by compartment (overall, stroma, or tumor). We assessed the association between log transformed TIIC scores and BCSS using Cox regression. Results Total CD8+ and CD20+ TIICs (stromal and intra-tumoral) were associated with better BCSS in women with ER-negative (HR per standard deviation = 0.91 [95% CI 0.85 - 0.98] and 0.89 [0.84 - 0.94] respectively) and ER-positive disease (HR = 0.92 [95% CI 0.87 - 0.98] and 0.93 [0.86 - 0.99] respectively) in multi-marker models. In contrast, CD163+ macrophages were associated with better BCSS in ER-negative disease (0.94 [0.87 - 1.00]) and a poorer BCSS in ER-positive disease 1.04 [0.99 - 1.10]. There was no association between FOXP3 and BCSS. The observed associations tended to be stronger for intra-tumoral than stromal compartments for all markers. However, the TIIC markers account for only 7.6 percent of the variation in BCSS explained by the multi-marker fully-adjusted model for ER-negative cases and 3.0 percent for ER-positive cases. Conclusions The presence of intra-tumoral and stromal TIICs is associated with better BCSS in both ER-negative and ER-positive breast cancer. This may have implications for the use of immunotherapy. However, the addition of TIICs to existing prognostic models would only result in a small improvement in model performance.
空间分辨肿瘤浸润免疫细胞与乳腺癌预后
背景乳腺肿瘤中的免疫反应在预后中起着重要作用,但免疫细胞的空间定位和亚型之间的相互作用还没有得到很好的描述。我们在一项大型多中心研究中评估了空间分辨组织浸润免疫细胞(TIICs)与乳腺癌特异性生存(BCSS)之间的关系。患者和方法对17265名欧洲血统乳腺癌患者的肿瘤核组织芯片进行了CD8、FOXP3、CD20和CD163染色。我们开发了一种基于机器学习的组织分割和免疫细胞检测算法,使用 Halo 对每张图像的标记阳性细胞百分比进行分区(整体、基质或肿瘤)评分。我们使用 Cox 回归评估了对数变换的 TIIC 分数与 BCSS 之间的关联。结果在多标记物模型中,CD8+和CD20+ TIIC总数(基质和肿瘤内)与ER阴性(每个标准差的HR分别为0.91 [95% CI 0.85 - 0.98]和0.89 [0.84 - 0.94])和ER阳性(HR分别为0.92 [95% CI 0.87 - 0.98]和0.93 [0.86 - 0.99])女性的BCSS相关。相比之下,CD163+巨噬细胞在ER阴性疾病中与较好的BCSS相关(0.94 [0.87 - 1.00]),而在ER阳性疾病中与较差的BCSS相关(1.04 [0.99 - 1.10])。FOXP3 与 BCSS 之间没有关联。就所有标记物而言,观察到的瘤内相关性往往强于基质区。然而,在ER阴性病例和ER阳性病例中,TIIC标记物仅占多标记物完全调整模型所解释的BCSS变化的7.6%和3.0%。这可能会对免疫疗法的使用产生影响。不过,在现有的预后模型中加入TIIC只会使模型的性能略有提高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信